AI Assistant

Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol

Toxicology and Exposure
142.00

Private Drugs of Abuse Profile in London for £142, screening a random urine sample for alcohol and common drugs without formal chain-of-custody collection.

Turnaround time

1 day

Biomarkers count

1

Reordering your previous test
We've pre-selected your previous add-ons ({{ selectedAddOns.length }}). You can still remove any or add new ones. Pick your clinic and time — the rest is set from your last order.
Enhance Your Panel
{{ availableAddOns.length }} extra tests · sorted by relevance
×
No tests match "{{ addOnSearch }}"
{{ selectedAddOns.length }} test{{ selectedAddOns.length !== 1 ? 's' : '' }} added +£{{ addOnsTotal.toFixed(2) }}
Same-Day Appointments
UKAS Accredited Labs

Book your test

Under 18? Patients under 18 can only be seen at GB Medlabs and Clinilabs, Monday to Friday only.
1
Email
2
Service
3
Details
4
Confirm
{{ emailError }}
Choose Service Type
Home visit

Professional phlebotomist comes to you

+ £{{ home_visit_fee }}

In clinic

Visit our clinic for your test

{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}

Home Visit Details
{{ homeAddressError }}

Home visits require at least 24 hours notice.

{{ homeTimeError }}
Note: Home visits are not available on Sundays
Select a clinic: Sorting by distance…
{{ clinic.name }}

{{ clinic.full_address }}

{{ clinic.distance.toFixed(1) }} mi
{{ selectedClinic.name }}

{{ selectedClinic.full_address }}

Select a date
{{ timeSlotAlert }}
Note: Bookings are not available on Sundays
Select an hour

Available time slots: {{ timeSlots.length}}

{{ selectedAddOns.length }} extra test{{ selectedAddOns.length !== 1 ? 's' : '' }} added +£{{ addOnsTotal.toFixed(2) }}
Please confirm your consent before proceeding.

Overview of the Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol

The Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol is a toxicology screen that checks a random urine sample for alcohol and a range of commonly encountered drugs and drug metabolites.

The laboratory profile screens for 11 analytes: Alcohol, Amphetamines, Barbiturates, Benzodiazepine, Cannabinoids, Cocaine, Codeine – opiate, Dihydrocodeine – opiate, MDMA, Methadone and Morphine – opiate.

Urine drug screening is primarily designed to identify evidence of relatively recent exposure. The period during which a substance remains detectable varies considerably according to the drug, dose, frequency of use, individual metabolism, kidney function, urine concentration and time since exposure.

An initial screening result is not always the same as a definitive identification of a drug. Screening methods are designed to identify substances or classes of substances above defined laboratory cut-offs.

Where confirmation is required following a reactive result, more specific analytical methods such as LC-MS/MS may be performed. The laboratory turnaround is normally around 2 business days, increasing to approximately 5 business days where LC-MS/MS confirmation is required.

This particular profile is explicitly performed without chain of custody.

That distinction is important. A no-chain-of-custody sample can provide useful clinical or personal information, but the identity, possession and transfer of the specimen are not documented using the strict procedures required for legally defensible drug testing.

It is therefore not the appropriate test where formal forensic, court, employment, legal or regulatory chain-of-custody documentation is required.

A positive screening result should be interpreted alongside prescribed medicines, over-the-counter products, timing of exposure and confirmatory testing where appropriate.

What Does the Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol Test Check?

This test screens 11 analytes.

Drugs of Abuse and Alcohol

Alcohol - Screens the random urine specimen for evidence of alcohol exposure according to the laboratory method and analytical cut-off used.

Amphetamines - Screens for amphetamine-class substances or metabolites detectable by the laboratory assay.

Barbiturates - Screens for drugs within the barbiturate class.

Benzodiazepine - Screens for benzodiazepine-related compounds or metabolites detectable by the laboratory method.

Cannabinoids - Screens for cannabinoid metabolites associated with cannabis exposure.

Cocaine - Screens for cocaine exposure, typically through detection of relevant urinary metabolites.

Codeine – opiate - Screens for codeine as part of the opiate component of the profile.

Dihydrocodeine – opiate - Screens for dihydrocodeine within the opiate component of the profile.

MDMA - Screens for MDMA exposure according to the laboratory assay used.

Methadone - Screens for methadone or relevant metabolites where included by the laboratory method.

Morphine – opiate - Screens for morphine within the opiate component of the profile.

Who May Benefit From the Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol Test?

This profile may be useful where a private, non-forensic assessment of recent drug or alcohol exposure is required.

People wanting a private toxicology screen - The profile provides laboratory testing for several commonly encountered substances using a random urine sample.

People reviewing possible recent substance exposure - Testing can provide objective laboratory information where exposure is uncertain.

People taking prescribed medicines that may appear on a drug screen - Results can be reviewed alongside medication history where a clinician needs additional information.

People undergoing clinical substance-use assessment - Urine screening may form part of a wider healthcare assessment when substance use is relevant to treatment.

People requiring monitoring without a legal chain of custody - The profile can be used where formal forensic documentation is not required.

People with a previous reactive drug screen - Repeat or confirmatory testing may help clarify an earlier result.

Clinicians requiring a broad urine drug screen - The profile can provide supporting information when drug exposure may affect diagnosis, medication safety or clinical management.

People specifically requiring alcohol to be included - This profile includes alcohol in addition to the laboratory's random-urine drug screen.

Symptoms and Reasons to Consider the Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol Test

Drug testing is generally guided by exposure history or a clinical reason rather than by one specific symptom pattern.

Unexpected drowsiness or altered alertness - Sedating medicines or substances can contribute to impaired consciousness, although many medical conditions can cause similar symptoms.

Unexplained agitation or marked stimulation - Stimulant exposure may be one consideration within a wider clinical assessment.

Unexpected behavioural or cognitive changes - Toxicology testing may provide additional information where recent substance exposure is clinically relevant.

Possible accidental or unrecognised drug exposure - A broad urine screen may help identify whether one of the included substances is detectable.

Medication-safety concerns - Toxicology results can sometimes provide useful context when several sedating or interacting medicines are involved.

Previous unexplained positive drug-screen result - Repeat testing and, where appropriate, laboratory confirmation may help clarify the finding.

Clinical monitoring of substance use - Testing may form part of an agreed treatment or monitoring programme where formal chain of custody is unnecessary.

A urine drug screen does not determine whether someone is currently impaired, exactly when a substance was taken or the precise amount consumed.

Detection windows differ significantly between substances and between individuals.

A reactive screening result may require confirmatory analysis before firm conclusions are drawn.

Severe drowsiness, difficulty breathing, collapse, seizure, marked confusion or suspected overdose requires urgent medical assessment rather than routine private toxicology testing.

How to Prepare

Fasting
Fasting is not required for this urine toxicology profile.
Hydration
Drink normally before providing the sample. Avoid deliberately drinking excessive volumes of water because an unusually dilute specimen may affect interpretation.
Medication
Provide an accurate list of prescribed and over-the-counter medicines. Some medications or metabolites may be relevant when interpreting screening results.
Supplements
Tell the clinician or laboratory about any supplements or non-prescription products being used where relevant.
Sample collection
A fresh random urine specimen is required in the laboratory-approved container.
Chain of custody
This profile does not use formal chain-of-custody procedures. Do not select it where legally defensible specimen identity and handling are required.
Timing
Detection depends on how recently a substance was taken, the drug involved and individual metabolism. Record relevant exposure timing where known.
Previous results
Keep previous screening or confirmatory toxicology results where available.

Do not deliberately take a substance in order to test whether it appears on the screen.

Where testing is required for court proceedings, employment, regulatory purposes or another setting requiring forensic defensibility, a formal chain-of-custody service should be used instead.

How to Book Your Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol Test

Booking this private random urine Drugs of Abuse Profile with London Blood Tests is straightforward.

1
Choose the Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol

Select the profile online and review the included substances and no-chain-of-custody limitation.

2
Select your sample collection option

Arrange an appropriate urine specimen collection or submission option and obtain the correct laboratory container.

3
Attend your appointment

Provide the random urine sample according to the collection instructions supplied.

4
Laboratory analysis

Your specimen is screened for the included drugs and alcohol, with confirmatory analysis undertaken where required.

5
Receive your results securely

Your authorised toxicology report is delivered securely and can be reviewed with an appropriately qualified healthcare professional.

When Will I Receive My Results?

The expected turnaround time for the Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol is approximately 2 business days after the specimen enters the laboratory system.

Where an initial result requires LC-MS/MS confirmation, turnaround may extend to approximately 5 business days.

Timing begins when the laboratory receives and registers the specimen.

Understanding Your Results

A negative screening result means the laboratory did not detect the relevant substance or metabolite above the assay cut-off in the submitted specimen.

It does not prove that a substance has never been taken.

Exposure may have occurred outside the detection window, concentrations may be below the analytical cut-off or the substance may not be included in this particular profile.

A reactive or positive screening result means the assay detected evidence consistent with the relevant drug or drug class above its screening threshold.

Screening tests can occasionally cross-react with prescribed medicines or related compounds.

Confirmatory analysis using a more specific analytical technique may therefore be important before a result is considered definitive.

The result does not determine the exact dose taken or whether the person was impaired at the time the sample was collected.

Because this profile does not use chain of custody, the report should not be treated as equivalent to a forensic or legally defensible drug-testing result.

Why Book With London Blood Tests?

Private toxicology testing in London - Access a broad random-urine drug and alcohol screen privately.

Multiple drugs assessed in one profile - The associated laboratory screen covers 11 named analytes.

Alcohol included - This version includes alcohol alongside the drugs-of-abuse screen.

Confirmation available where required - Reactive screens may require more specific LC-MS/MS analysis.

Clear non-forensic purpose - The profile is explicitly offered without formal chain of custody.

Specialist laboratory analysis - Urine is processed using established toxicology screening methods.

Secure results by email - Receive your authorised laboratory report confidentially.

Clear pricing before booking - The profile is priced at £142, with any applicable sample-collection charges shown separately.

Private Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol Test in London

London Blood Tests provides the Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol in London for private clinical or personal toxicology assessment.

The profile costs £142 and screens a random urine specimen for alcohol and 10 named drug analytes within the associated laboratory profile.

It is intended for situations where formal legal chain-of-custody procedures are not required.

If testing is needed for court, employment, regulatory or forensic purposes, a chain-of-custody service should be selected instead.

Results are usually available approximately 2 business days after laboratory receipt, or around 5 business days where LC-MS/MS confirmation is required.

Frequently Asked Questions

The associated laboratory profile screens Alcohol, Amphetamines, Barbiturates, Benzodiazepine, Cannabinoids, Cocaine, Codeine, Dihydrocodeine, MDMA, Methadone and Morphine.

No. It uses a random urine specimen.

It means the sample is not collected, documented and transferred using the formal identity-verification procedures required for legally defensible forensic testing.

It should not be relied upon where formal chain-of-custody evidence is required. A dedicated chain-of-custody test should be used for those situations.

No. The substance may have been taken outside its urine detection window, may be below the assay cut-off or may not be included in the profile.

Not necessarily. Screening assays can occasionally cross-react, which is why confirmatory laboratory analysis may be required.

Liquid chromatography tandem mass spectrometry is a highly specific analytical method used to confirm and identify drugs or metabolites following selected reactive screening results.

Yes. Your medication history should be provided because some prescribed or over-the-counter medicines may be relevant to interpretation.

Not reliably. Urine detection primarily indicates whether the relevant substance or metabolite is present above the laboratory cut-off.

No. Detection in urine does not establish the degree of impairment at a particular time.

No. Normal hydration is appropriate. Deliberately excessive fluid intake can produce a very dilute specimen.

Screening results are generally expected in approximately 2 business days, increasing to around 5 business days where LC-MS/MS confirmation is required.
+44 203 488 0809 WhatsApp